efavirenz (33342-013) | FunFoxMeds NDC

Drug Facts

Product Profile

Brand Name efavirenz

Generic Name efavirenz

Labeler macleods pharmaceuticals limited

Dosage Form TABLET

Routes

ORAL

Active Ingredients

efavirenz 600 mg/1

Manufacturer

Macleods Pharmaceuticals Limited

Identifiers & Regulatory

Product NDC 33342-013

Product ID 33342-013_f1a4251a-e04d-48aa-ae58-44b30df1de0d

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA091579

Listing Expiration 2026-12-31

Marketing Start 2024-05-10

Pharmacologic Class

Established (EPC)

human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor [epc]

Mechanism of Action

non-nucleoside reverse transcriptase inhibitors [moa] cytochrome p450 3a inducers [moa] cytochrome p450 2b6 inducers [moa] cytochrome p450 2c9 inhibitors [moa] cytochrome p450 2c19 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 33342013

Hyphenated Format 33342-013

Supplemental Identifiers

RxCUI

349477

UNII

JE6H2O27P8

NUI

N0000175463 N0000175460 N0000009948 N0000190118 N0000187064 N0000185504 N0000182140 N0000182141

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name efavirenz (source: ndc)

Generic Name efavirenz (source: ndc)

Application Number ANDA091579 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

600 mg/1

source: ndc

Packaging

30 TABLET in 1 BOTTLE (33342-013-07)

source: ndc

Packages (1)

33342-013-07 30 TABLET in 1 BOTTLE (33342-013-07)

Ingredients (1)

efavirenz (600 mg/1)

Linked Drug Pages (1)

Efavirenz ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "f1a4251a-e04d-48aa-ae58-44b30df1de0d", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064", "N0000185504", "N0000182140", "N0000182141"], "unii": ["JE6H2O27P8"], "rxcui": ["349477"], "spl_set_id": ["13ca3456-e5bf-4bb1-af95-b1378658a358"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (33342-013-07)", "package_ndc": "33342-013-07", "marketing_start_date": "20240510"}], "brand_name": "Efavirenz", "product_id": "33342-013_f1a4251a-e04d-48aa-ae58-44b30df1de0d", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "33342-013", "generic_name": "Efavirenz", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Efavirenz", "active_ingredients": [{"name": "EFAVIRENZ", "strength": "600 mg/1"}], "application_number": "ANDA091579", "marketing_category": "ANDA", "marketing_start_date": "20240510", "listing_expiration_date": "20261231"}